Arax Advisory Partners
NUS icon

Arax Advisory Partners’s Nu Skin NUS Stock Holding History

Arax Advisory Partners’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.4K Buy
5,598
+4,397
+366% +$21.7K ﹤0.01% 3847
2026
Q2 		$6.34K Buy
1,201
+733
+157% +$4.69K ﹤0.01% 4526
2026
Q1 		$3.41K Buy
468
+314
+204% +$2.84K ﹤0.01% 2951
2025
Q4 		$1.48K Sell
154
-8,951
-98% -$92.6K ﹤0.01% 3370
2025
Q3 		$111K Buy
9,105
+8,953
+5,890% +$94K ﹤0.01% 1500
2025
Q2 		$1.22K Sell
152
-2,281
-94% -$16K ﹤0.01% 2718
2025
Q1 		$17.7K Buy
+2,433
New +$17.7K ﹤0.01% 1354
2024
Q4 		– Sell
-532
Closed -$3.92K – 2641
2024
Q3 		$3.92K Hold
532
– – ﹤0.01% 1818
2024
Q2 		$5.61K Buy
+532
New +$6.74K ﹤0.01% 1543

Other funds holding NUS

American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Arax Advisory Partners's NUS Position: Q3 2026 in Review

Arax Advisory Partners increased its Nu Skin (NUS) stake by 366% in Q3 2026, buying an estimated $21.7K and bringing the position to 5,598 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Arax Advisory Partners first reported a position in NUS in Q2 2024 and has held it in 9 quarters since. The position peaked at $111K in Q3 2025. 102 funds tracked by Wall St. Rank hold NUS as of Q3 2026.

  • Arax Advisory Partners held 5,598 shares of Nu Skin worth $25.4K as of Q3 2026.
  • Arax Advisory Partners bought 4,397 Nu Skin shares in Q3 2026, an estimated $21.7K.
  • Nu Skin made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #3847 holding.
  • Arax Advisory Partners first reported a position in Nu Skin in Q2 2024 and has held it in 9 quarters since.
  • Arax Advisory Partners's Nu Skin position peaked at $111K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Nu Skin as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.